- Home
- ALGS vs SVIAW Comparison
ALGS vs SVIAW Comparison
Compare ALGS & SVIAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$5.58
Company Overview
Basic Information| Metric | ALGS | SVIAW |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6M | 39.1M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ALGS | SVIAW |
|---|---|---|
| Price | $5.58 | $0.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $52.38 | N/A |
| AVG Volume (30 Days) | ★ 39.1K | 1.7K |
| Earning Date | 11-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,186,000.00 | N/A |
| Revenue This Year | $1,562.10 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.98 | $0.41 |
| 52 Week High | $13.69 | $0.49 |
Technical Indicators
Market Signals| Indicator | ALGS | SVIAW |
|---|---|---|
| Relative Strength Index (RSI) | 50.09 | N/A |
| Support Level | $4.81 | N/A |
| Resistance Level | $6.12 | N/A |
| Average True Range (ATR) | 0.38 | 0.00 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 58.78 | 0.00 |
Price Performance
Historical Comparison ALGS
SVIAW
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.